Volume Alert - GPRO 77.80 Gopro Inc. $GPRO Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - GPRO 77.80 Gopro Inc. $GPRO Hit a high today of 78.50 Closing the day 10:30 at 77.80 +1.33 +1.74% With a day low of 76.75 and a total volume of 1,621,534.

GPRO Recent Posts: http://investorshangout.com/GoPro-Inc-GPRO-54268/

GPRO Gopro Inc. Recent Headline News

Scour Mutual Fund Special Sections For Great Ideas
at Investor's Business Daily - Wed Nov 12, 3:59PM CST
Institutional sponsorship is a key factor to check when researching stocks to buy. Why? Without demand from mutual funds, hedge funds and other big investors, which account for most of the market's daily activity, a stock cannot keep advancing....
GPRO: 77.45 (+0.98), ESRX: 77.94 (+0.04), WY: 33.92 (-0.03), MA: 84.23 (+0.03)

The Alarm Bell Has Sounded - Time To Short These 2 Recent IPOs
Weighing Machine - at Seeking Alpha - Wed Nov 12, 1:50PM CST

GPRO: 77.45 (+0.98), LOCO: 34.06 (-0.44)

Why GoPro Inc. Investors Shouldn't Worry About Insiders Cashing In
Alex Planes, The Motley Fool - Motley Fool - Wed Nov 12, 8:16AM CST
Brace yourselves, GoPro investors: a sell-off is coming. Source: user farioff via Pixabay. A mere 16% of the red-hot action-cam company's shares have been traded on public markets since GoPro's IPO this summer, and the stock has risen...
GPRO: 77.45 (+0.98), TWTR: 41.02 (+0.98), ZNGA: 2.72 (-0.01)

Time to Panic About the Recent GoPro (GPRO) Stock Sell-Off? - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Tue Nov 11, 12:18PM CST
GoPro just did a secondary stock offering, should investors be worried?
GPRO: 77.45 (+0.98)

GoPro Announces Secondary Stock Offering, Shares Slide - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 12:07PM CST
Share price of GoPro, Inc. (GPRO) has yet again plummeted 4.2% on Monday, Nov 11, after the company announced a filing of a secondary offering.
SKUL: 8.43 (+0.09), GPRO: 77.45 (+0.98)

GoPro (GPRO) Stock Lower Today on Stock Offering
at The Street - Tue Nov 11, 11:51AM CST
GoPro (GPRO) stock is down in midday trading after the company filed plans for an offering of $800 million in shares, after raising $491 million in its June IPO.
GPRO: 77.45 (+0.98)

GoPro and Its CEO Want to Cash in on Its Soaring Share Price
Evan Niu, CFA, The Motley Fool - Motley Fool - Tue Nov 11, 11:17AM CST
Just four months after going public, GoPro shares have soared. At the peak, shares had more than quadrupled the $24 offering price. With the stock enjoying such impressive performance amid investor optimism, GoPro has decided to take advantage of...
GPRO: 77.45 (+0.98)

Vuzix: The GoPro Killer
Ugly Duckling - at Seeking Alpha - Tue Nov 11, 6:10AM CST

GPRO: 77.45 (+0.98)

How GoPro Has Shareholder Interests In Mind
Joe Albano - at Seeking Alpha - Tue Nov 11, 2:24AM CST

GPRO: 77.45 (+0.98)

GoPro's $800 Million Move: Don't Fear The Dilution
Tyler Lacoma - at Seeking Alpha - Tue Nov 11, 2:20AM CST

GPRO: 77.45 (+0.98)

GoPro down on 2nd stock offer
at Investor's Business Daily - Mon Nov 10, 5:56PM CST
The action camera maker announced a follow-on stock offering in a regulatory filing, less than 5 months after its IPO . GoPro (GPRO) plans to sell $100 mil in new shares to provide itself "additional resources to invest in people, products,...
GPRO: 77.45 (+0.98)

Stock Market Today: Another Record Close for S&P 500, Dow
at The Street - Mon Nov 10, 3:09PM CST
The Dow and S&P 500 clock another day of record closing highs, the latest win in a three-week rally, despite the absence of any market-moving news.
GPRO: 77.45 (+0.98), KSS: 56.41 (+0.34), M: 62.00 (+0.43), NFLX: 383.37 (+3.96), T: 35.88 (+0.27), GOGO: 17.78 (-0.10), TWC: 139.71 (-1.34), CMCSA: 53.89 (-0.41), TOL: 33.53 (-0.20), BABA: 115.12 (+0.28)

Alibaba's Massive Revenue on China's 'Singles Day;' Are Target, GoPro Buys?
at The Street - Mon Nov 10, 3:05PM CST
CNBC's 'Fast Money' trading panel believe shares of Alibaba will have momentum going into 2015, while U.S. consumers will continue to benefit from lower gas prices.
BID: 41.17 (+0.04), GPRO: 77.45 (+0.98), NSC: 116.29 (+0.84), KWEB: 38.27 (+0.69), DDD: 33.59 (+0.20), TLT: 119.34 (+0.43), SPY: 204.15 (-0.04), QQQ: 103.09 (+0.19), TGT: 67.98 (+0.48), DIA: 176.36 (-0.08), MCD: 96.16 (+0.68), DF: 16.71 (+0.04), IWM: 116.84 (-0.06), BABA: 115.12 (+0.28)

GoPro Stumbles On Secondary Stock Offering
at Investor's Business Daily - Mon Nov 10, 2:18PM CST
Less than five months after its initial public offering, action camera maker GoPro (GPRO) announced a follow-on stock offering in a regulatory filing on Monday. GoPro plans to sell $100 million in new shares and allow some large shareholders in the...
GPRO: 77.45 (+0.98)

Stock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba Spikes
at The Street - Mon Nov 10, 2:02PM CST
Though the S&P 500 has rallied to record highs over the past three weeks, analysts predict markets will continue to climb through to year's end.
KSS: 56.41 (+0.34), GPRO: 77.45 (+0.98), DNDN: 0.11 (-0.02), MCD: 96.16 (+0.68), M: 62.00 (+0.43), TWC: 139.71 (-1.34), TOL: 33.53 (-0.20), CMCSA: 53.89 (-0.41), BABA: 115.13 (+0.29)

Stock Movers: Why These 5 Top Stocks Are Rising Today
at Investor's Business Daily - Mon Nov 10, 1:04PM CST
Here is why shares of biotech Gilead Sciences (GILD) and three four other highly rated stocks are rallying in heavy volume today. Gilead began running up in premarket trading after drug giant Merck (MRK) said Sunday it would not move forward with...
DHI: 24.45 (+0.16), AMBA: 47.66 (-0.08), GPRO: 77.45 (+0.98), HCA: 63.04 (-1.73), LEN: 45.73 (+0.07), YY: 76.10 (+4.43), GILD: 101.96 (-2.24), CYH: 45.65 (-0.55), MRK: 58.90 (-0.64), TASR: 20.47 (+0.83), TOL: 33.53 (-0.20), DGLY: 11.71 (-1.51)

Jim Cramer Explains Why GoPro Secondary Offering Is a Buy
at The Street - Mon Nov 10, 10:14AM CST
TheStreet's Jim Cramer says shares of GoPro can go back to $90, while homebuilder stocks may be a solid 'catch-up' trade going into year's end.
DHI: 24.45 (+0.16), GPRO: 77.45 (+0.98), TOL: 33.53 (-0.20)

Stock Market Today: Wall Street Is Static With Little News to Move Markets
at The Street - Mon Nov 10, 9:44AM CST
U.S. stocks make little movement on Monday following a three-week rally.
KSS: 56.41 (+0.34), GPRO: 77.45 (+0.98), DNDN: 0.11 (-0.02), MCD: 96.16 (+0.68), M: 61.99 (+0.42), TWC: 139.71 (-1.34), TOL: 33.53 (-0.20), CMCSA: 53.89 (-0.41)

GoPro (GPRO) Stock Declines After Filing to Sell $800 Million in Common Stock
at The Street - Mon Nov 10, 9:00AM CST
GoPro (GPRO) stock is lower this morning after the company filed to sell $800 million in common stock.
GPRO: 77.45 (+0.98)

GoPro -4.4% after filing for $800M offering
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 8:37AM CST

GPRO: 77.45 (+0.98)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading